Use of rituximab in the treatment of pemphigus vulgaris in a juvenile patient
Introduction: Pemphigus vulgaris is a chronic autoimmune blistering disorder characterised by the production of autoantibodies against desmogleins, resulting in intraepithelial blister formation. Despite advancements in treatment options, some patients experience disease progression and an inadequat...
Saved in:
Main Authors: | Hanna Róża Cisoń (Author), Wojciech Baran (Author), Rafał Białynicki-Birula (Author) |
---|---|
Format: | Book |
Published: |
Termedia Publishing House,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020) -
Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
by: Sepideh Ashrafzadeh, BS, et al.
Published: (2020) -
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
by: Stephanie Del Rio Navarrete Biot, et al.
Published: (2014) -
Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
by: Inês Aparício-Martins, et al.
Published: (2022) -
Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
by: Nikolay N. Murashkin, et al.
Published: (2022)